# A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

> **NCT00831129** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Chicago** · enrollment: 53 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Placebo Rosiglitazone
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00831129
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2017-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831129, "A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00831129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*